Découvrez nos professeurs et professeures!

Louis Bessette

Médecin clinicien enseignant agrégé

Louis Bessette
Centre de recherche du CHU de Québec - Université Laval
Centre de recherche en arthrite (ARThrite)
Partager la fiche :

Contribution à la recherche

Axe de recherche de l'Université Laval :

Santé et bien-être durables

Thématiques de recherche de la Faculté de médecine :

Immunologie-infectiologie

Domaines et intérêts de recherche du (de la) professeur(e) :

Appareil locomoteur et arthrite
  • Arthrite/arthrose
  • Articulations

Projets de recherche

  • Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis - La société d'arthrite, co-chercheur - 2020-01-01 au 2022-12-31

Publications

  • Bronchial responsiveness to methacholine in swine confinement building workers, Cormier, W., Tremblay, G., Boulet, L.P., Bessette, L., Archives of Environmental Health, 1993, 10.1080/00039896.1993.9938397
  • Predictors of outcomes of carpal tunnel release, Keller, R.B., Bessette, L., Fossel, A.H., Amick III, B.C., Losina, E., Katz, J.N., Arthritis and Rheumatism, 2001, 10.1002/1529-0131(200105)44:5<1184::AID-ANR202>3.0.CO;2-A
  • Comparative Responsiveness of Generic Versus Disease-Specific and Weighted Versus Unweighted Health Status Measures in Carpal Tunnel Syndrome, Katz, J.N., Fossel, A.H., Lew, R.A., Keller, R.B., Kuntz, K.M., Sangha, O., Bessette, L., Medical Care, 1998, 10.1097/00005650-199804000-00005
  • Prognostic value of a hand symptom diagram in surgery for carpal tunnel syndrome, Katz, JN, Mooney, N, Fossel, AH, Simmons, BP, Lew, RA, Keller, RB, Bessette, L, The Journal of Rheumatology, 1997
  • Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD, Lentle, B.C., Vigna, Y., Prior, J.C., Allan, J., Thingvold, J., Davison, K.S., Pickard, L., Gardner-Bray, B., Murray, T., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Joyce, C., Berger, C., Godmaire, S., Poliquin, S., Tenenhouse, A., Jamal, S.A., Olszynski, W.P., Papaioannou, A., Josse, R., Kreiger, N., Hanley, D.A., Adachi, J.D., Kovacs, C.S., Goltzman, D., Langsetmo, L., Journal of Bone and Mineral Research, 2009, 10.1359/jbmr.090319
  • The care gap in diagnosis and treatment of women with a fragility fracture, Brown, J.P., Bessant, J., Baranci, M., Beaulieu, M., Davison, K.S., Jean, S., Ste-Marie, L.-G., Bessette, L., Osteoporosis International, 2008, 10.1007/s00198-007-0426-9
  • Changes in body mass index in Canadians over a five-year period: Results of a prospective, population-based study, Vigna, Y., Allan, J., Hanley, D.A., Thingvold, J., Davison, K.S., Olszynski, W.P., Pickard, L., Papaioannou, A.A., Adachi, J.D., Kreiger, N., Gardner-Bray, B., Murray, T., Josse, B., Matthews, B., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Tenenhouse, A., Goltzman, D., Anastassiades, T., Towheed, T., Poliquin, S., Harrison, M., Prior, J.C., Barr, S.I., Joseph, L., Berger, C., Leroux, C., Hopman, W.M., BMC Public Health, 2007, 10.1186/1471-2458-7-150
  • The association between body mass index and health-related quality of life: Data from CaMos, a stratified population study, Vigna, Y., Allan, J., Hanley, D.A., Thingvold, J., Davison, K.S., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Kreiger, N., Gardner-Bray, B., Murray, T., Josse, B., Matthews, B., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Tenenhouse, A., Goltzman, D., Anastassiades, T., Towheed, T., Prior, J.C., Poliquin, S., Gao, Y., Barr, S.I., Joseph, L., Berger, C., Hopman, W.M., Quality of Life Research, 2007, 10.1007/s11136-007-9273-6
  • CURATA: A patient health management program for the treatment of osteoarthritis in Quebec: An integrated approach to improving the appropriate utilization of anti-inflammatory/analgesic medications, Carrier, R, Bessette, L, Rahme, E, Choquette, D, Beaulieu, M, American Journal of Managed Care, 2004
  • Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: A placebo-controlled trial, Blanchette, C., Bensen, W., Bell, M., Thorne, C., Bykerk, V., Frémont, P., Morin, F., Bessette, L., Tardif, J., Moffet, H., Carette, S., Arthritis and Rheumatism, 2003, 10.1002/art.10954
  • Heterogeneous disease trajectories explain variable radiographic, function and quality of life outcomes in the Canadian Early Arthritis Cohort (CATCH), Lyddell, C., Penney, C., Mosher, D., Hazlewood, G., Nair, B., Ahluwalia, V., Bensen, W., Rubin, L., Akhavan, P., Bessette, L., Baron, M., Zummer, M., Kraishi, M., Bykerk, V.P., Bartlett, S., Keystone, E.C., Pope, J.E., Jamal, S., Curtis, J.R., Van Der Heijde, D., Tin, D., Thorne, J.C., Haraoui, B., Hitchon, C.A., Boire, G., Sun, Y., Barnabe, C., PLoS ONE, 2015, 10.1371/journal.pone.0135327
  • Response to: "Drugs and cardiovascular risk in inflammatory arthritis: Another case of glucocorticoid-bashing?" by Dr Boers, Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Gulliver, W., Pope, J., Lynde, C., Kraft, J., Siu, S., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2015-207419
  • High Body Mass Index Is a Risk Factor for Low Trauma Fractures in Women Who Have Sustained an Upper Arm or Lower Leg Fracture, Brown, Jacques P., Ste-Marie, Louis-Georges, Bessette, Louis, Jean, Sonia, Beaudoin, Claudia, Journal of Bone and Mineral Research, 2014
  • Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada, Lachaine, J., Légaré, J., Bernatsky, S., Rahme, E., Bessette, L., Roussy, J.-P., Rheumatology International, 2014, 10.1007/s00296-013-2828-7
  • Rheumatoid arthritis prevalence in Quebec, Joseph, L., Feldman, D.E., Bergeron, L., Belisle, P., Chetaille, A.L., Jean, S., Bessette, L., Fortin, P.R., Boire, G., Pineau, C.A., Hudson, M., Dekis, A., Bernatsky, S., BMC Research Notes, 2014, 10.1186/1756-0500-7-937
  • Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over, Lachaine, J., Rahme, E., Bernatsky, S., Bessette, L., Roussy, J.-P., Osteoporosis International, 2013, 10.1007/s00198-013-2321-x
  • Direct medical costs attributable to peripheral fractures in Canadian post-menopausal women, Brown, J.P., Ste-Marie, L.G., Davison, K.S., Belzile, E.L., Lapointe-Garant, M.-P., Jean, S., Bessette, L., Osteoporosis International, 2012, 10.1007/s00198-011-1785-9
  • The burden of illness of osteoporosis in Canada, Goeree, R., Brown, J.P., Bessette, L., Papaioannou, A., Adachi, J.D., Morin, S., Leslie, W.D., Hopkins, R.B., Tarride, J.-E., Osteoporosis International, 2012, 10.1007/s00198-012-1931-z
  • The burden of illness of osteoporosis in Canadian men, Goeree, R., Brown, J.P., Bessette, L., Papaioannou, A., Adachi, J.D., Morin, S., Leslie, W.D., Hopkins, R., Guo, N., Tarride, J.-E., Journal of Bone and Mineral Research, 2012, 10.1002/jbmr.1615
  • Treating rheumatoid arthritis to target: A Canadian physician survey, Wade, J., Thorne, C., Le Clercq, S., Bessette, L., Bensen, W., Haraoui, B., Journal of Rheumatology, 2012, 10.3899/jrheum.111134
  • An Open-Label Pilot Study Evaluating by Magnetic Resonance Imaging the Potential for a Disease-Modifying Effect of Celecoxib Compared to a Modelized Historical Control Cohort in the Treatment of Knee Osteoarthritis, Pelletier, J.-P., Abram, F., Haraoui, B., Choquette, D., Morin, F., Bessette, L., Beaulieu, A., Martel-Pelletier, J., Raynauld, J.-P., Seminars in Arthritis and Rheumatism, 2010, 10.1016/j.semarthrit.2009.10.003
  • Evaluation of abatacept in biologic-naïve patients with active rheumatoid arthritis, Bessette, L., Schiff, M., Clinical Rheumatology, 2010, 10.1007/s10067-009-1363-0
  • Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative, Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Gulliver, W., Pope, J., Lynde, C., Kraft, J., Siu, S., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Journal of Rheumatology, 2015, 10.3899/jrheum.141112
  • Effect of biologics on depressive symptoms in patients with psoriasis: A systematic review, Gulliver, W.P., Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Pope, J.E., Lynde, C., Kraft, J., Siu, S., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Fleming, P., Journal of the European Academy of Dermatology and Venereology, 2015, 10.1111/jdv.12909
  • Real-world validation of the minimal disease activity index in psoriatic arthritis: An analysis from a prospective, observational, biological treatment registry, Tkaczyk, C., Osborne, B., Nantel, F., Lehman, A.J., Psaradellis, E., Rampakakis, E., Kapur, S., Kelsall, J., Chow, A., Haraoui, B., Baer, P., Bessette, L., Zummer, M., Rahman, P., BMJ Open, 2017, 10.1136/bmjopen-2017-016619
  • Identifying flares in rheumatoid arthritis: Reliability and construct validation of the OMERACT RA Flare Core Domain Set, Zummer, M., Thorne, C., Rubin, L., Penney, C., Nair, B., Lyddell, C., Larche, M., Kraishi, M., Kinkhoff, A., Colmegna, I., Bessette, L., Bensen, W., Baron, M., Akhavan, P., Ahluwalia, V., Voshaar, M.S., Pohl, C., Orbai, A.-M., Montie, P., May, J.E., Lyddiatt, A., Guillemin, F., Fautrel, B., Den Broeder, A., Boonen, A., Bartlett, S.J., Thorne, J.C., Tin, D., Pope, J., Keystone, E.C., Jamal, S., Hitchon, C., Haraoui, B., Boire, G., Woodworth, T., March, L., Leong, A., Hewlett, S., Furst, D.E., Christensen, R., Alten, R., Lin, D., Choy, E.H., Bingham, C.O., Bykerk, V.P., RMD Open, 2016, 10.1136/rmdopen-2015-000225
  • Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis, Zummer, M., Klinkhoff, A., Lyddell, C., Penney, C., Ahluwahlia, V., Colmegna, I., Larche, M., Akhavan, P., Bessette, L., Rubin, L., Bensen, W., Keystone, E.C., Bartlett, S., Baron, M., Bykerk, V., Keystone, E., Jamal, S., Hitchon, C., Tin, D., Thorne, J.C., Haraoui, B., Boire, G., Pope, J., Xiong, J., Lin, D., Schieir, O., Kuriya, B., Clinical and Experimental Rheumatology, 2017
  • Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study, Laliberté, M.-C., Latour, M.G., Gazel, S., Gaetano, T., Oraichi, D., Millson, B., Gerega, S.K., Lebovic, G., Shear, N.H., Thorne, C., Bessette, L., Marshall, J.K., Clinical Therapeutics, 2018, 10.1016/j.clinthera.2018.02.001
  • Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study, Thorne, J.C., Laliberté, M.-C., Latour, M.G., Gazel, S., Gaetano, T., Millson, B., Glass, J., Lebovic, G., Shear, N.H., Bessette, L., Marshall, J.K., Clinical Therapeutics, 2018, 10.1016/j.clinthera.2018.04.017
  • Stressful life events are common in the year prior to RA onset and are associated with worse symptoms and QOL, Bartlett, Susan, Bykerk, Vivian, Keystone, Ed, Tin, Diane, Hazlewood, Glen, Hitchon, Carol, Pope, Janet, Thorne, Carter, Bessette, Louis, Boire, Gilles, Valois, Marie-France, Schieir, Orit, Andersen, Nicole, Quality of Life Research, 2019
  • ACHIEVING A LOW DISEASE STATE WITHIN FIRST 3 MONTHS IN EARLY RHEUMATOID ARTHRITIS RESULTS IN LOWER FATIGUE OVER 5 YEARS, Pope, Janet, Bykerk, Vivian, Thorne, Carter, Tin, Diane, Keystone, Edward, Hitchon, Carol, Hazlewood, Glen, Boire, Gilles, Bessette, Louis, Bartlett, Susan J., Schieir, Orit, Holdren, Melissa, Annals of the Rheumatic Diseases, 2019, 10.1136/ANNRHEUMDIS-2019-EULAR.4414
  • A quarter of patients time their early rheumatoid arthritis onset differently than physicians, Pope, J., Bykerk, V.P., Thorne, C., Tin, D., Keystone, E., Hitchon, C., Hazlewood, G.S., Boire, G., Bessette, L., Bartlett, S.J., Schieir, O., Kudaeva, F., Ellingwood, L., RMD Open, 2019, 10.1136/rmdopen-2019-000931
  • Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study, Saeed Shaikh, Jerry Syrotuik, Irina Bogatyreva, Fabienne Staelens, Sami Elmoufti, Derek Haaland, Majed Khraishi, Sanjay Dixit, Isabelle Fortin, Andrew Chow, Boulos Haraoui, Louis Bessette, Therapeutic Advances in Musculoskeletal Disease, 2019, 10.1177/1759720X19831151
  • Differences in fracture prevalence and in bone mineral density between Chinese and White Canadians: the Canadian Multicentre Osteoporosis Study (CaMos), Leslie, W.D., Jackson, S.D., Patel, M.S., Lentle, B., Kalyan, S., Prior, J.C., Boyd, S.K., Hanley, D.A., Davison, K.S., Olszynski, W.P., Papaioannou, A., Adachi, J.D., Wong, A.K.O., Josse, R.G., Cheung, A.M., Hopman, W.M., Towheed, T., Anastassiades, T.P., Bessette, L., Brown, J.P., Kaiser, S.M., Kirkland, S., Kovacs, C.S., Joyce, C., Berger, C., Richards, J.B., Rahme, E., Tenenhouse, A., Kreiger, N., Goltzman, D., Rahme, E., Papaioannou, A., Wong, A.K.O., Boyd, S.K., Hanley, D.A., Cheung, A.M., Prior, J.C., Liu, W., Berger, C., Morin, S.N., Archives of Osteoporosis, 2020, 10.1007/s11657-020-00822-4
  • INFECTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH GOLIMUMAB, Asin-Milan, Odalis, Nantel, Francois, Rachich, Meagan, Lehman, Allen J., Rampakakis, Emmanouil, Purvis, Jane, Kelsall, John, Rahman, Proton, Bessette, Louis, Internal Medicine Journal, 2020
  • Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial, Pantojas, C., Toro-Torres, R., Soto-Raices, O., Perez-De Jesus, A., Rivera, T.L., Thai, C., Diegel, R.J., Mabaquiao, A.R., Harris, M.D., Mease, P.J., Goddard, D.H., Kimmel, S.C., Sebai, M.B., Mallepalli, J.R., Hull, J.E., Roseff, R., Shanahan, J.C., Scoville, C.D., Sayers, M.E., Querubin, R., Peters, E.A., Mueller, E.C., Klein, S.J., Kivitz, A., Kaine, J.L., Howell, M.P., Greenwald, M., Flint, K.P., Churchill, M.A., Rebroy, A., Ershova, O., Yakushin, S., Stanislav, M., Schmidt, E., Matsievskaya, G., van de Sande, M.G., Tronaru, L., Ramazan, A.M., Opris-Belinski, D., Krogulec, M., Brzezicki, J., Drabiszcak-Piatkowska, J., Plebanski, R., Hrycai, P., Dudek, A., Blicharshi, T., Braun, J., Wagner, S., Neeck, G., Takakubo, Y., Matsui, K., Honjo, S., Goto, H., Atsumi, T., Hatta, K., Matsumoto, Y., Ueki, Y., Inui, K., Dobashi, H., Tada, K., Tsuda, T., Taniguchi, Y., Paimela, L., Karjalainen, A., Jarvinen, P., Eklund, K.K., Pvelka, K., Malcova, M., Dvorak, Z., Dokoupilova, E., Lee, S.-H., Park, M.-C., Lee, S.H., Lee, E.B., Lee, C.K., Kang, S.W., Hong, S.-J., Rodriguez, J.C.R., Remus, C.R.R., Tena, C.F.P., Skinner, C.M., Barragan, S.D., Molina, F.F.C., Rodriguez, A.A.B., Scotton, A.S., Roimicher, L., Melazzi, A.C., Scheinecker, C., Resch, H., Grisar, J., Viola, D.O., Velasco, J., Hidalgo, R.P., Cocco, J.M., Lucero, E., Carrio, J., Berman, A., Ariel, F., Rahman, P., Morin, F., Sieper, J., Carlier, H., Adams, D., Li, X., Gallo, G., Hojnik, M., Leung, A., Tomita, T., Bessette, L., Marzo-Ortega, H., Poddubnyy, D., Østergaard, M., Maksymowych, W.P., Kim, T.-H., Gensler, L.S., van der Heijde, D., Deodhar, A., The Lancet, 2020, 10.1016/S0140-6736(19)32971-X
  • MAPPING REAL-WORD RHEUMATOID ARTHRITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA, Rachich, Meagan, Nantel, Francois, Asin-Milan, Odalis, Lehman, Allen J., Rampakakis, Emmanouil, Rahman, Proton, Bessette, Louis, Olsynski, Wojciech, Keystone, Ed, Internal Medicine Journal, 2020
  • Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort, Zummer, M., Villeneuve, E., Rubin, L., Penney, C., Panopoulos, P., Nair, B., Joshi, R., Jamal, S., Jamal, S., Haraoui, P., Haaland, D., Fallavollita, S., Colmegna, I., Bessette, L., Baron, M., Bernatsky, S., Bykerk, V.P., Tin, D., Keystone, E.C., Hazlewood, G.S., Haraoui, B., Boire, G., Hitchon, C.A., Pope, J.E., Bartlett, S.J., Thorne, C., Valois, M.-F., Schieir, O., Moura, C.S., Arthritis Care and Research, 2020, 10.1002/acr.23927
  • What are the rheumatology educational preferences of family medicine residents? A descriptive study, Michou, L., Bessette, L., Rheault, C., Julien, A.-S., Lagacé, S., Clinical Rheumatology, 2020, 10.1007/s10067-020-05018-2
  • An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis, Martel-Pelletier, J., Paiement, P., Pavelka, K., Morin, F., Dokoupilova, E., Bessette, L., Dorais, M., Raynauld, J.-P., Pelletier, J.-P., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/keaa072
  • APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN ANKYLOSING SPONDYLITIS PATIENTS, Lehman, Allen J., Nantel, Francois, Rachich, Meagan, Asin-Milan, Odalis, Rampakakis, Emmanouil, Rahman, Proton, Bessette, Louis, Inman, Robert, Maksymowych, Walter, Internal Medicine Journal, 2020
  • Prediction of Osteoporotic Fractures in Elderly Individuals: A Derivation and Internal Validation Study Using Healthcare Administrative Data, Jacques P. Brown, Louis-Georges Ste-Marie, Louis Bessette, Philippe Gamache, Lynne Moore, Sonia Jean, Claudia Beaudoin, Journal of Bone and Mineral Research, 2020, 10.1002/jbmr.4438
  • Switching between janus kinase inhibitor upadacitinib and adalimumab following insufficient response: Efficacy and safety in patients with rheumatoid arthritis, Song, I.-H., Demasi, R., Song, Y., Li, Y., Enejosa, J., Bessette, L., Zerbini, C., Van Den Bosch, F.E., Thomson, G.T.D., Hall, S., Blanco, R., Fleischmann, R.M., Annals of the Rheumatic Diseases, 2021, 10.1136/annrheumdis-2020-218412
  • Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study, Song, I.-H., Li, Y., Bu, X., Khan, N., Swierkot, J., Tanaka, Y., Durez, P., Peterfy, C.G., Bessette, L., Mysler, E., Fleischmann, R., RMD Open, 2022, 10.1136/rmdopen-2021-002012
  • A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort, Vivian P. Bykerk, J Carter Throne, Diane Tin, Janet Pope, Edward C. Keystone, Carol Hitchon, Glen Hazlewood, Boulos Haraoui, Gilles Boire, Louis Bessette, Susan J. Bartlett, Marie‐France Valois, Orit Schieir, Kathleen M. Andersen, ACR Open Rheumatology, 2022, 10.1002/acr2.11334
  • Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials, Ronald F. van Vollenhoven, Phu Vinh On, Tatjana Lukic, Kenneth Kwok, Cassandra D. Kinch, Eduardo Mysler, Louis Bessette, The Journal of Rheumatology, 2022, 10.3899/jrheum.210707
  • Drs. Bessette and Kinch reply, Cassandra D. Kinch, Louis Bessette, The Journal of Rheumatology, 2023, 10.3899/jrheum.220909
  • Prevalence and predictors of long-term work disability due to carpal tunnel syndrome, Keller, R.B., Mooney, N., Fossel, A.H., Punnett, L., Bessette, L., Lew, R.A., Katz, J.N., American Journal of Industrial Medicine, 1998, 10.1002/(SICI)1097-0274(199806)33:6<543::AID-AJIM4>3.0.CO;2-R
  • Late onset leflunomide-induced cutaneous ulcers in a seronegative arthritis patient: A case report., Veillette H, Bessette L, Grenier PO, Couture-Lapointe C, SAGE open medical case reports, 2023, 10.1177/2050313x231195480
  • Does the Type of Failure and the Choice of the Second Biologic Influence Response and Persistence on Medication in Rheumatoid Arthritis?, Keystone E, Kane K, Kremer JM, Reed G, Movahedi M, Bessette L, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2023, 10.1097/rhu.0000000000002013
  • A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia, Lew, R.A., Fossel, A.H., Carette, S., Bessette, L., Scandinavian Journal of Rheumatology, 1998, 10.1080/030097498440976
  • Factors influencing the treatment of osteoporosis following fragility fracture, Brown, J.P., Ste-Marie, L.-G., Roy, S., Davison, K.S., Jean, S., Bessette, L., Osteoporosis International, 2009, 10.1007/s00198-009-0898-x
  • Factors influencing diagnosis and treatment of osteoporosis following a fragility fracture, Ste-Marie, Louis-Georges, Bessant, Jennifer, Baranci, Mirela, Beaulieu, Michele, Davison, K. Shawn, Jean, Sonia, Brown, Jacques P., Bessette, Louis, The Journal of Rheumatology, 2008
  • Recognizing osteoporosis and its consequences in Quebec (ROCQ): Background, rationale, and methods of an anti-fracture patient health-management programme, Brown, J.P., Bessant, J., Baranci, M., Beaulieu, M., Shawn Davison, K., Jean, S., Ste-Marie, L.-G., Bessette, L., Contemporary Clinical Trials, 2008, 10.1016/j.cct.2007.07.007
  • Maine carpal tunnel study: Outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort, Mooney, N.A., Fossel, A.H., Bessette, L., Rogers, W.D., Simmons, B.P., Keller, R.B., Katz, J.N., Journal of Hand Surgery, 1998, 10.1016/S0363-5023(98)80058-0
  • Validation of a clinical definition for fragility fracture, Ste-Marie, Louis-Georges, Bessant, Jennifer, Beaulieu, Michele, Davison, K. Shawn, Jean, Sonia, Bessette, Louis, Brown, Jacques P., The Journal of Rheumatology, 2008
  • Advantages and limitations of utility assessment methods in rheumatoid arthritis, Duru, G., Bombardier, C., Bessette, L., Haraoui, B., Russell, A.S., Beresniak, A., Journal of Rheumatology, 2007
  • An integrated approach to improving appropriate use of anti-inflammatory medication in the treatment of osteoarthritis in Québec (Canada): The CURATA model, Thivierge, R.L., Rahme, E., Choquette, D., Bessette, L., Fournier, C., Paquette, D., Beaulieu, M., Labelle, M., Medical Teacher, 2004, 10.1080/0142159042000218669
  • Calcium and Vitamin D intake and mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos), Andjelic, N., Allan, J., Thingvold, J., Olszynski, W.P., Pickard, L., Gardner-Bray, B., Murray, T., Josse, B., Matthews, B., Dumont, J., Bessette, L., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Joyce, C., Dumont, S., Godmaire, S., Tenenhouse, A., Goltzman, D., Davison, K.S., Leslie, W.D., Adachi, J.D., Papaioannou, A., Josse, R.G., Towheed, T., Anastasiades, T., Brown, J.P., Patel, M.S., Lentle, B., Prior, J.C., Hodsman, A., Morin, S.N., Genest, J., Whiting, S.J., Jamal, S.A., Hanley, D.A., Kovacs, C.S., Kreiger, N., Berger, C., Langsetmo, L., Journal of Clinical Endocrinology and Metabolism, 2013, 10.1210/jc.2013-1516
  • Direct medical resource utilization associated with osteoporosis-related nonvertebral fractures in postmenopausal women, Brown, J.P., Dodin, S., Morin, S., Candas, B., Shawn Davison, K., Belzile, E.L., Bessette, L., Jean, S., Journal of Bone and Mineral Research, 2013, 10.1002/jbmr.1756
  • Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): A systematic literature review of randomized controlled trials, Bykerk, V., Thorne, C., Mosher, D., Leclercq, S., Hochman, J., Haraoui, B., Flanagan, C., Bessette, L., Kung, T., Kalache, F., Barnabe, C., Li, L., Thiessen-Philbrook, H., Pope, J.E., Steiman, A.J., Rheumatology International, 2013, 10.1007/s00296-012-2619-6
  • The Burden of Osteoporotic Fracture: Epidemiology and Health-care Utilisation in Older Adults, 1997-2010, Brown, Jacques P., Gagne, Mathieu, Morin, Suzanne, Belzile, Etienne, Bessette, Louis, Gamache, Philippe, Jean, Sonia, Journal of Bone and Mineral Research, 2013
  • Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate, Pelletier, J.-P., Wildi, L.M., Morin, F., Bessette, L., Beaulieu, A., Abram, F., Choquette, D., Haraoui, B., Dorais, M., Martel-Pelletier, J., Raynauld, J.-P., Cartilage, 2013, 10.1177/1947603513483547
  • Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture, Lentle, B.C., Vigna, Y., Patel, M., Allan, J., Thingvold, J., Davison, K.S., Olszynski, W.P., Pickard, L., Papaioannou, A., Gardner-Bray, B., Murray, T., Jamal, S.A., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Joyce, C., Berger, C., Godmaire, S., Poliquin, S., Tenenhouse, A., Kreiger, N., Goltzman, D., Eisman, J.A., Hanley, D.A., Adachi, J.D., Josse, R.G., Morin, S., Center, J.R., Prior, J.C., Kovacs, C.S., Nguyen, N.D., Nguyen, T.V., Langsetmo, L., CMAJ, 2011, 10.1503/cmaj.100458
  • Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass, Bone, H.G., MacArios, D., Siddhanti, S., Wagman, R.B., Man, H.-S., Wang, H., Borenstein, J., Varon, S.F., Horne, R., Gold, D.T., Hill, C.D., Bessette, L., Kendler, D.L., Osteoporosis International, 2010, 10.1007/s00198-009-1023-x
  • Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis, Dupont, D., Maclean, R., Thorne, C., Rahman, P., Haraoui, B., Bessette, L., Beresniak, A., Russell, A., Clinical Rheumatology, 2009, 10.1007/s10067-008-1060-4
  • Dr. Roubille, et al reply, Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Gulliver, W., Lynde, C., Kraft, J., Siu, S., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Journal of Rheumatology, 2016, 10.3899/jrheum.151347
  • How to attract trainees, a pan-canadian perspective: Phase 1 of the "training the rheumatologists of tomorrow" project, Crawshaw, D., Lohfeld, L., Yacyshyn, E., Shojania, K., Robinson, D., Pope, J., Khalidi, N., Hazel, E., Bessette, L., Barr, S., Bakowsky, V., Cividino, A., Journal of Rheumatology, 2016, 10.3899/jrheum.150314
  • Loss of health related quality of life following low-trauma fractures in the elderly, Hopkins, R.B., Muratov, S., Pericleous, L., Brown, J.P., Bessette, L., Papaioannou, A., Adachi, J.D., Morin, S.N., Leslie, W.D., Burke, N., Tarride, J.-E., BMC Geriatrics, 2016, 10.1186/s12877-016-0259-5
  • Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: Results from the Canadian Early Arthritis Cohort, White, K., Wehlage, A., Vasconcelos, S., Urroz, L., Strecko, J., Sniderman, F., Poirier, N., Papachristos, A., Ouellet, M., McBain, D., Matthews, J., Maguire, L., Magnusson, C., Luc, L., Legge, G., Larsen, T., L'Archevêque, J., Kislinsky, D., Moyen, M., Harrison, T., Harris, B., Guillet, C., Glenn, N., Cottrell, J., Cheng, C., Buchignani, M., Bain, L., Zummer, M., Villeneuve, E., Sutton, E., Shaw, E., Rubin, L., Penney, C., Norris, E., Nair, B., Mosher, D., Menard, H., Lyddell, C., Larche, M., Kraishi, M., Kinkhoff, A., Haraoui, P., Colmegna, I., Cividino, A., Bykerk, V., Bessette, L., Bensen, B., Bell, M., Baron, M., Arbillaga, H., Akhavan, P., Ahluwalia, V., Bykerk, V.P., Thorne, C., Tin, D., Jamal, S., Pope, J., Keystone, E., Haraoui, B., Boire, G., Hitchon, C.A., Rheumatology (United Kingdom), 2016, 10.1093/rheumatology/kew061
  • The current economic burden of illness of osteoporosis in Canada, Tarride, J., Pericleous, L., Brown, J.P., Bessette, L., Papaioannou, A., Adachi, J.D., Morin, S.N., Leslie, W.D., Von Keyserlingk, C., Burke, N., Hopkins, R.B., Osteoporosis International, 2016, 10.1007/s00198-016-3631-6
  • The longterm effect of early intensive treatment of seniors with rheumatoid arthritis: A comparison of 2 population-based cohort studies on time to joint replacement surgery, Bernatsky, S., Feldman, D., Hanly, J.G., Bombardier, C., Bessette, L., Fortin, P.R., Boire, G., Beauchamp, M.-E., Huang, A., Michael Paterson, J., Abrahamowicz, M., Wang, Y., Moura, C.S., Widdifield, J., Journal of Rheumatology, 2016, 10.3899/jrheum.151156
  • The impact of educational interventions on modifiable risk factors for osteoporosis after a fragility fracture, Brown, J.P., Ste-Marie, L.-G., Jean, S., Bessette, L., Beaudoin, C., Osteoporosis International, 2014, 10.1007/s00198-014-2618-4
  • Rates of non-vertebral osteoporotic fractures in rheumatoid arthritis and postfracture osteoporosis care in a period of evolving clinical practice guidelines, Lachaine, J., Rahme, E., Bernatsky, S., Bessette, L., Roussy, J.-P., Calcified Tissue International, 2014, 10.1007/s00223-014-9856-5
  • The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: A systematic review and meta-analysis, Haraoui, B., Bissonnette, R., Bessette, L., Dutz, J., Keeling, S., Gulliver, W., Pope, J., Lynde, C., Kraft, J., Siu, S., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2014-206624
  • Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study - Comparing site and age-specific risks in women and men, Jackson, S., Morin, S., Richards, B., ElhamRahme, Andjelic, N., Vigna, Y.M., Patel, M., Allan, J., Boyd, S., Hanley, D.A., Thingvold, J., Davison, K.S., Olszynski, Wojciech, P., Pickard, L., Gardner-Bray, B., Cheung, A.M., Jamal, S., Rees-Milton, K., Hopman, W., Gendreau, M., Bessette, L., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Joyce, C., Robertson, L., Bastien, D., Mailloux, L., Lentle, B., Dumont, S., Godmaire, S., Poliquin, S., Tenenhouse, A., Kreiger, N., Leslie, W.D., Brown, J.P., Josse, R.G., Towheed, T., Anastassiades, T., Papaioannou, A., Adachi, J.D., Kaiser, S.M., Kovacs, C.S., Goltzman, D., Berger, C., Lentle, B.C., Langsetmo, L., Prior, J.C., Bone, 2015, 10.1016/j.bone.2014.10.026
  • Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials, Pope, J.E., Dutz, J., Keeling, S., Gulliver, W., Lynde, C., Kraft, J., Fleming, P., McFarlane, A., McCourt, C., Starnino, T., Richer, V., Roubille, C., Bessette, L., Bissonnette, R., Haraoui, B., Siu, S., Arthritis Care and Research, 2015, 10.1002/acr.22519
  • 2014 update of the canadian rheumatology association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part II: Specific management recommendations, Inman, R.D., Gladman, D.D., Rahman, P., Thorne, C., Mallinson, M., Adams, K., Keen, K.J., Flanagan, C., Mosher, D., Bessette, L., Chandran, V., Haroon, N., Tse, S.M.L., Chan, J., Rohekar, S., Journal of Rheumatology, 2015, 10.3899/jrheum.141001
  • The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis, Zummer, M., Villeneuve, S., Thorne, C., Tremblay, J.-L., Rubin, L., Pope, J., Penney, C., Nair, B., Lyddell, C., Larche, M., Kuriya, B., Keystone, E., Jamal, S., Hazlewood, G., Haraoui, B., Haaland, D., Fallavollita, S., Colmegna, I., Bykerk, V., Boire, G., Bessette, L., Baron, M., Bartlett, S., Barnabe, C., Barber, C., Barra, L., Akhavan, P., Ahluwalia, V., Bykerk, V.P., Jamal, S., Haraoui, B., Keystone, E.C., Tin, D., Thorne, C.J., Lin, D., Schieir, O., Boire, G., Hitchon, C., Pope, J.E., Barra, L.J., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kew474
  • Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: Analysis from a Canadian administrative database, Maslova, K., Nantel, F., Tkaczyk, C., Bell, M.J., Bessette, L., Bhoi, P., BMJ Open, 2017, 10.1136/bmjopen-2017-015872
  • Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study, West, C.R., Viktrup, L., Tive, L., Prucka, W.R., Pixton, G., Brown, M.T., Davignon, I., Bessette, L., Khan, A., Schnitzer, T.J., Seminars in Arthritis and Rheumatism, 2020, 10.1016/j.semarthrit.2020.03.004
  • An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs, Sampalis, J.S., Haraoui, B., Lazovskis, J., Bessette, L., Vaillancourt, J., Rampakakis, E., Pope, J., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/kez470
  • Major stressors in the year prior to disease onset affects RA characteristics at baseline and 12 months: results from the Canadian Early Arthritis Cohort (CATCH), Bartlett, Susan, Bykerk, Vivian, Keystone, Edward, Hazlewood, Glen, Hitchon, Carol, Pope, Janet, Thorne, Carter, Tin, Diane, Bessette, Louis, Boires, Gilles, Andersen, Kathleen, Valois, Marie-France, Schieir, Orit, Andersen, Nicole, Quality of Life Research, 2020
  • Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study, Thorne, C., Laliberté, M.-C., Gazel, S., Latour, M.G., Remple, V., Gaetano, T., Donepudi, K., Charland, K., Millson, B., Lebovic, G., Bessette, L., Rheumatology and Therapy, 2018, 10.1007/s40744-018-0109-3
  • Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial, Poor, G., Drescher, E., Cseuz, R., Balazs, T., Rebrov, A., Ershova, O., Yakushin, S., Stanislav, M., Shmidt, E., Matsievskaya, G., Nurmohamed, M., Griep, E., van de Sande, M., Wojciechowski, R., Racewicz, A., Dudek, A., Blicharski, T., Szymanska, M., Rubbert-Roth, A., Poddubnyy, D., Neeck, G., Takakubo, Y., Matsui, K., Goto, H., Atsumi, T., Hatta, K., Koyama, Y., Matsumoto, Y., Ueki, Y., Inui, K., Dobashi, H., Tada, K., Kishimoto, M., Taniguchi, Y., Malcova, M., Moravcova, R., Dvorak, Z., Lan, J.-L., Hsieh, S.-C., Chen, Y.-C., Chen, H.-A., Lee, S.-H., Shin, K., Park, M.-C., Lee, S.H., Lee, E.B., Lee, C.K., Kim, T.-H., Kang, S.W., Ju, J.H., Lee, Y.-A., Hong, S.-J., Rizo Rodriguez, J.C., Ramos Remus, C., Pacheco Tena, C., Skinner, C., Duran Barragan, S., Cons-Molina, F., Barrera Rodriguez, A.A., Rahman, P., Morin, F., Bessette, L., Thai, C., Diegel, R., Roseff, R., Reveille, J., Querubin, R., Peters, E., Mehta, D., Ince, A., Kaine, J., Howell, M., Greenwald, M., Gladstein, G., Flint, K., Churchill, M., Carlier, H., Pangallo, B., Adams, D.H., Zhao, F., Krishnan, E., Landewé, R., Tomita, T., Sieper, J., Van den Bosch, F., Maksymowych, W.P., Deodhar, A., Mease, P., Dougados, M., Cheng-Chung Wei, J., van der Heijde, D., The Lancet, 2018, 10.1016/S0140-6736(18)31946-9
  • Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis, Bernatsky, S., Bessette, L., Abrahamowicz, M., Maksymowych, W.P., Rahme, E., Moura, C.S., Scandinavian Journal of Rheumatology, 2019, 10.1080/03009742.2018.1470253
  • Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial, Genovese, M.C., Othman, A.A., Li, Y., Zhou, Y., Ostor, A.J., Durez, P., Peterfy, C., Bessette, L., Mysler, E., Song, I.-H., Pangan, A.L., Fleischmann, R., Arthritis and Rheumatology, 2019, 10.1002/art.41032
  • Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response, Song, I.-H., Li, Y., Ostor, A., Durez, P., Peterfy, C., Bessette, L., Mysler, E., Enejosa, J.V., Genovese, M.C., Fleischmann, R.M., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2019-215764
  • Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression, Jean, S., Brown, J.P., Ste-Marie, L.G., Bessette, L., Gagné, M., Moore, L., Beaudoin, C., Osteoporosis International, 2019, 10.1007/s00198-019-04919-6
  • Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort, Dougados, M., Haraoui, P., Wendling, D., Claudepierre, P., D'Agostino, M.-A., Michou, L., Bessette, L., Etcheto, A., Moltó, A., Nadon, V., Clinical and experimental rheumatology, 2019
  • SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAMME, Burmester, Gerd Rudiger, Enejosa, Jeffrey V., Hendrickson, Barbara, Khan, Nasser, Zhang, Ying, Bessette, Louis, Tanaka, Yoshiya, Zerbini, Cristiano, Winthrop, Kevin, van Vollenhoven, Ronald, Cohen, Stanley B., Rheumatology, 2020
  • APPLICATION OF TREAT TO TARGET AND IMPACT OF SUSTAINED LOW DISEASE ACTIVITY OR REMISSION ON FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS, Asin-Milan, Odalis, Nantel, Francois, Rachich, Meagan, Lehman, Allen J., Rampakakis, Emmanouil, Anderson, Keltie, Rahman, Proton, Keystone, Ed, Bessette, Louis, Internal Medicine Journal, 2020
  • Safety profile of upadacitinib in rheumatoid arthritis: Integrated analysis from the SELECT phase III clinical programme, Burmester, G.R., Enejosa, J.V., Hendrickson, B., Khan, N., Zhang, Y., Bessette, L., Tanaka, Y., Zerbini, C.A.F., Winthrop, K.L., Van Vollenhoven, R.F., Cohen, S.B., Annals of the Rheumatic Diseases, 2021, 10.1136/annrheumdis-2020-218510
  • Classics in spine: Surgery literature revisited, Weinstein, J.N., Lew, R.A., Liang, M.H., Bessette, L., Spine, 1996, 10.1097/00007632-199602010-00001
  • “From Where I Stand”: using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ), M Zummer, E Villeneuve, L Rubin, P Panopoulos, B Nair, R Joshi, S Jamal, B Haraoui, D Haaland, S Fallavollita, I Colmegna, M Baron, Clifton O. Bingham, III, Diane Tin, Carter Thorne, Edward Keystone, Louis Bessette, Glen Hazlewood, Carol Hitchon, Gilles Boire, Janet E. Pope, Marie-France Valois, Orit Schieir, Vivian P. Bykerk, Susan J. Bartlett, Quality of Life Research, 2023, 10.1007/s11136-022-03227-7
  • Reply, Pope, J.E., Bykerk, V.P., Thorne, C., Tin, D., Hitchon, C., Hazlewood, G., Boire, G., Bessette, L., Bartlett, S.J., Valois, M.F., Keystone, E.C., Schieir, O., Fatima, S., Arthritis and Rheumatology, 2022, 10.1002/art.41918
  • Expectations and educational needs of rheumatologists, rheumatology fellows and patients in the field of precision medicine in Canada, a quantitative cross-sectional and descriptive study, Michou, L., Dogba, M.J., Lacaille, D., Fortin, P.R., Bessette, L., Légaré, J., Simonyan, D., Ruel-Gagné, S., BMC Rheumatology, 2021, 10.1186/s41927-021-00222-2
  • Prognostic value of a hand symptom diagram in surgery for carpal tunnel syndrome, Katz, J.N., Mooney, N., Fossel, A.H., Simmons, B.P., Lew, R.A., Keller, R.B., Bessette, L., Journal of Rheumatology, 1997
  • Patients' preferences and their relationship with satisfaction following carpal tunnel release, Katz, J.N., Fossel, A.H., Simmons, B.P., Liang, M.H., Keller, R.B., Bessette, L., Journal of Hand Surgery, 1997, 10.1016/S0363-5023(97)80117-7
  • CURATA: A patient health management program for the treatment of osteoarthritis in Québec: An integrated approach to improving the appropriate utilization of anti-inflammatory/analgesic medications, Carrier, R., Bessette, L., Rahme, E., Choquette, D., Beaulieu, M., American Journal of Managed Care, 2004
  • Predictors of return to work following carpal tunnel release, Mooney, N., Simmons, B.P., Bessette, L., Punnett, L., Fossel, A.H., Keller, R.B., Katz, J.N., American Journal of Industrial Medicine, 1997, 10.1002/(SICI)1097-0274(199701)31:1<85::AID-AJIM13>3.0.CO;2-3
  • Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: A systematic literature review, Bykerk, V., Haraoui, B., Bessette, L., Pope, J., Barra, L., Rheumatology, 2011, 10.1093/rheumatology/keq190
  • Early medication use in new-onset rheumatoid arthritis may delay joint replacement: Results of a large population-based study, Bernatsky, S., Edworthy, S., Barnabe, C., Peschken, C., Maksymowych, W., Feldman, D., Hanly, J.G., Widdifield, J., Bombardier, C., Bessette, L., Fortin, P.R., Wang, Y., Boire, G., Lacaille, D., Beauchamp, M.-E., Abrahamowicz, M., Moura, C.S., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0713-3
  • Antidepressant use and 10-year incident fracture risk: The population-based Canadian Multicentre Osteoporosis Study (CaMoS), Rahme, E., Fraser, L.-A., Pickard, L., Ioannidis, G., Kaiser, S., Leslie, W.D., Towheed, T., Kreiger, N., Prior, J., Goltzman, D., Adachi, J., Bessette, L., Papaioannou, A., Abrahamowicz, M., Bernatsky, S., Moura, C., Osteoporosis International, 2014, 10.1007/s00198-014-2649-x
  • The presence of meniscal lesions is a strong predictor of neuropathic pain in symptomatic knee osteoarthritis: A cross-sectional pilot study, Pelletier, J.-P., Martel-Pelletier, J., Beaulieu, A.D., Bessette, L., Delorme, P., Dorais, M., Paiement, P., Abram, F., Raynauld, J.-P., Roubille, C., Arthritis Research and Therapy, 2014, 10.1186/s13075-014-0507-z
  • Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population, Lelorier, J., Toubouti, Y., Joseph, L., Bessette, L., Beaulieu, M., Choquette, D., Rahme, E., American Journal of Medicine, 2005, 10.1016/j.amjmed.2005.03.026
  • Advantages and limitations of utility assessment methods in rheumatoid arthritis, Duru, Gerard, Bombardier, Claire, Bessette, Louis, Haraoui, Boulos, Russell, Anthony S., Beresniak, Ariel, The Journal of Rheumatology, 2007
  • Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents, Vigna, Y., Prior, J.C., Allan, J., Thingvold, J., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Gardner-Bray, B., Murray, T., Jamal, S., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Poliquin, S., Goltzman, D., Tenenhouse, A., Kreiger, N., Josse, R., Hanley, D.A., Davison, K.S., Joseph, L., Langsetmo, L., Berger, C., CMAJ, 2008, 10.1503/cmaj.071416
  • Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective, Zlateva, G., Ho, J., Roussy, J.-P., Mittmann, N., Risebrough, N., Bessette, L., Journal of Medical Economics, 2009, 10.3111/13696990903288970
  • Association between change in BMD and fragility fracture in women and men, Vigna, Y., Lentle, B., Allan, J., Thingvold, J., Josse, B., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Gardner-Bray, B., Murray, T., Jamal, S., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Poliquin, S., Goltzman, D., Tenenhouse, A., Kreiger, N., Prior, J.C., Josse, R.G., Davison, K.S., Hanley, D.A., Joseph, L., Langsetmo, L., Berger, C., Journal of Bone and Mineral Research, 2009, 10.1359/jbmr.081004
  • Peak bone mass from longitudinal data: Implications for the prevalence, pathophysiology, and diagnosis of osteoporosis, Vigna, Y., Lentle, B., Patel, M., Allan, J., Thingvold, J., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Gardner-Bray, B., Murray, T., Jamal, S., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Godmaire, S., Poliquin, S., Josse, R.G., Prior, J.C., Hanley, D.A., Davison, K.S., Kreiger, N., Tenenhouse, A., Jackson, S., Joseph, L., Langsetmo, L., Goltzman, D., Berger, C., Journal of Bone and Mineral Research, 2010, 10.1002/jbmr.95
  • The impact of two educational interventions on osteoporosis diagnosis and treatment after fragility fracture: A population-based randomized controlled trial, Brown, J.P., Ste-Marie, L.G., Roy, S., Jean, S., Davison, K.S., Bessette, L., Osteoporosis International, 2011, 10.1007/s00198-011-1533-1
  • The burden of osteoporotic fractures beyond acute care: The Canadian Multicentre Osteoporosis Study (CaMos), Lentle, B.C., Vigna, Y., Patel, M., Prior, J.C., Allan, J., Hanley, D.A., Thingvold, J., Davison, K.S., Olszynski, W.P., Pickard, L., Papaioannou, A., Adachi, J.D., Gardner-Bray, B., Murray, T., Jamal, S.A., Josse, B., Matthews, B., Towheed, T., Anastassiades, T., Gendreau, M., Bessette, L., Brown, J.P., Stanfield, B., Kaiser, S., Kirkland, S., Sheppard, E., Kovacs, C., Joyce, C., Berger, C., Godmaire, S., Poliquin, S., Tenenhouse, A., Kreiger, N., Goltzman, D., Papaioannou, A., Papadimitropoulos, E., Adachi, J., Pickard, L., Oremus, M., Raina, P., Kaffashian, S., Age and Ageing, 2011, 10.1093/ageing/afr085
  • Algorithms can be used to identify fragility fracture cases in physician-claims databases, Brown, J.P., Dodin, S., Bessette, L., Morin, S., Belzile, É., Candas, B., Jean, S., Osteoporosis International, 2012, 10.1007/s00198-011-1559-4
  • Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: A randomised, double-blind, placebo-controlled pilot study using MRI, Pelletier, J.-P., Dorais, M., Abram, F., Morin, F., Bessette, L., Beaulieu, A., Martel-Pelletier, J., Raynauld, J.-P., Wildi, L.M., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.140848
  • Sex differences in pain scores and localization in inflammatory arthritis: A systematic review and metaanalysis, Bykerk, V., Thorne, C., Mosher, D., Hochman, J., Haraoui, B., Pope, J.E., Kung, T., Kalache, F., Steiman, A., LeClercq, S., Flanagan, C., Bessette, L., Barnabe, C., Journal of Rheumatology, 2012, 10.3899/jrheum.111393
  • Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: A 2-year multicentre exploratory study, Martel-Pelletier, J., Abram, F., Paiement, P., Dorais, M., Delorme, P., de Brum-Fernandes, A.J., Morin, F., Bessette, L., Beaulieu, A.D., Raynauld, J.-P., Pelletier, J.-P., Arthritis Research and Therapy, 2016, 10.1186/s13075-016-1149-0
  • Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis, Brown, J.P., Moore, L., Ste-Marie, L.-G., Bessette, L., Jean, S., Beaudoin, C., Osteoporosis International, 2016, 10.1007/s00198-016-3607-6
  • Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: A population-based study, Rahme, E., Nedjar, H., Bessette, L., Bernatsky, S., Machado, M.A.D.Á., BMC Musculoskeletal Disorders, 2016, 10.1186/s12891-016-1142-4
  • Opioid Use and Risk of Nonvertebral Fractures in Adults with Rheumatoid Arthritis: A Nested Case-Control Study Using Administrative Databases, Rahme, E., Bessette, L., Bernatsky, S., Moura, C.S., Acurcio, F.A., Arthritis and Rheumatology, 2016, 10.1002/art.39422
  • Psoriasis and smoking: A systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity, Bissonnette, R., Haraoui, B., Gulliver, W.P., Bessette, L., Dutz, J., Keeling, S., Pope, J.E., Lynde, C., Kraft, J., Siu, S., McFarlane, A., McCourt, C., Starnino, T., Fleming, P., Roubille, C., Richer, V., Journal of Cutaneous Medicine and Surgery, 2016, 10.1177/1203475415616073
  • 2014 update of the canadian rheumatology association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. part i: Principles of the management of spondyloarthritis in Canada, Inman, R.D., Gladman, D.D., Rahman, P., Thorne, C., Mallinson, M., Adams, K., Keen, K.J., Flanagan, C., Mosher, D., Bessette, L., Chandran, V., Haroon, N., Tse, S.M.L., Chan, J., Rohekar, S., Journal of Rheumatology, 2015, 10.3899/jrheum.141000
  • High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years, Joshi, R., Jamal, S., Penney, C., Nair, B., Rubin, L., Akhavan, P., Bessette, L., Zummer, M., Haaland, D., Fallavollita, S., Colmegna, I., Baron, M., Villeneuve, É., Morin, F., Bykerk, V.P., Denning, L., Pope, J.E., Tin, D., Keystone, E., Hitchon, C., Haraoui, B., Boire, G., Bartlett, S.J., Ahluwalia, V., Thorne, J.C., Hazlewood, G., Barnabe, C., Marshall, D.A., Lacaille, D., Schieir, O., Barber, C.E.H., Arthritis Care and Research, 2018, 10.1002/acr.23439
  • Number, Location, and Time Since Prior Fracture as Predictors of Future Fracture in the Elderly From the General Population, Brown, J.P., Ste-Marie, L.-G., Bessette, L., Gamache, P., Moore, L., Jean, S., Beaudoin, C., Journal of Bone and Mineral Research, 2018, 10.1002/jbmr.3526
  • Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis,Évaluation de l'impact d'une brochure d'information sur la connaissance des complications dans la sclérodermie systémique, Michou, L., Fortin, P.R., Bessette, L., Ikic, A., Beaudoin, C., Brown, J.P., Revue du Rhumatisme (Edition Francaise), 2015, 10.1016/j.rhum.2015.04.001
  • Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis, Michou, L., Fortin, P.R., Bessette, L., Brown, J.P., Beaudoin, C., Ikic, A., Joint Bone Spine, 2015, 10.1016/j.jbspin.2014.12.005
  • Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment, Collier, D., Isaila, M., Poulin-Costello, M., Grantab, R., Kaliyaperumal, A., Kivitz, A.J., Khraishi, M., Bessette, L., Rheumatology and Therapy, 2017, 10.1007/s40744-017-0079-x
  • Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study, Bernatsky, S., Boire, G., Fortin, P.R., Bessette, L., Gamache, P., Hudson, M., Jean, S., Clinical Rheumatology, 2017, 10.1007/s10067-017-3796-1
  • History of fractures for prediction of a future fracture in individuals from the general population, Brown, Jacques P., Ste-Marie, Louis-Georges, Bessette, Louis, Gamache, Philippe, Moore, Lynne, Jean, Sonia, Beaudoin, Claudia, Journal of Bone and Mineral Research, 2017
  • Sharing ongoing care with primary care physicians opens up opportunity for timelier and earlier care by rheumatologists for patients with new inflammatory polyarthritis, Michou, L., Fortin, P.R., Bessette, L., Julien, A.-S., Nguyen, P., Journal of Rheumatology, 2018, 10.3899/jrheum.170494
  • Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial, Camp, H.S., Pangan, A.L., Othman, A.A., Zhou, Y., Li, Y., Bessette, L., Kivitz, A., Van den Bosch, F., Kremer, J.M., Burmester, G.R., The Lancet, 2018, 10.1016/S0140-6736(18)31115-2
  • Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study, Zummer, M., Villeneuve, E., Tremblay, J.L., Rubin, L., Penney, C., Nair, B., Lyddell, C., Larche, M., Kuriya, B., Joshi, R., Hazlewood, G., Haaland, D., Fallavollita, S., Colmegna, I., Bykerk, V., Bessette, L., Baron, M., Barnabe, C., Barber, C., Barra, L., Akhavan, P., Ahluwalia, V., Bykerk, V.P., Goodman, S.M., Haraoui, B., Keystone, E.C., Tin, D., Thorne, J.C., Jamal, S., Hitchon, C., Pope, J.E., Boire, G., Andersen, K.M., Schieir, O., Bartlett, S.J., Schulman, E., Arthritis Care and Research, 2018, 10.1002/acr.23457
  • Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry, Coupal, L., Raynauld, J.-P., Postema, R., Haraoui, B., Alemao, E., Bessette, L., Choquette, D., Arthritis Research and Therapy, 2019, 10.1186/s13075-019-1917-8
  • Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study, de Morales, S.V., Ximenes, A.C., Radominski, S.C., Pinto, L.T., Pascual-Ramos, V., Melazzi, A.C.C., Keiserman, M.W., Jauregui, E.A., Hernandez, J.D.M., Jaller Raad, J.J., Maldonado-Lopez, M.C., Escalante, W.J.O., Cardiel-Rios, M.H., Brenol, J.C.T., de Freitas Zerbini, C.A., Vitek, P., Tseluyko, V.I., Stanislavchuk, M.A., Settas, L., Ruzga, Z., Rosa, J., Povoroznyuk, V.V., Pokrzywnicka-Gajek, I., Petrov, A., Oparanov, B., Mosterova, Z., Kopackova, J., Hrytsenko, H.M., Goranov, I., Dvorak, Z., Bichoversuska, D., Batalov, A., Yoo, B., Yamanaka, H., Wagh, S., Veeravalli, S.C.M., Ueki, Y., Tsai, W.-C., Tohma, S., Tanaka, Y., Takeuchi, T., Takasaki, Y., Shobha, V., Shim, S.C., Rao, U.R., Park, S.-H., Park, W., Ohta, S., Munakata, Y., Mori, S., Miyasaka, N., Miyamoto, T., Migita, K., Liu, M.-F., Liou, L.-B., Lin, H.-Y., Lee, S.-K., Lan, J.-L., Koh, E.-M., Kawabe, Y., Kadel, J.K., Iwahashi, M., Hsu, P.-N., Chopra, A.K., Chandrashekara, S., Bae, S.-C., Amano, K., Adhikari, P., Wolfe, S.M., Wells, A.F., Walsh, B.T., Taborn, J.D., Siva, C., Silverfield, J.C., Sikes, D.H., Shergy, W.J., Shamim, T., Schuette, P.T., Sayers, M.E., Palmer, W.R., Niemer, M.W., Moreland, L.W., Moorman, H.A., Misischia, R.J., Milton, A.C., Mathews, S.D., Longley, S., Kremer, J.M., Kolba, K.S., Kempf, K.J., Katzenstein, P.L., Kaine, J.L., Kafka, S.P., Jackson, R.E., Hill, G.L., Reddy Pasya, S.K., Bouda, D.W., Hargrove, J.K., Halter, D.G., Griffin, R.M., Fleischmann, R.M., Lohr, K.M., Dura, P.A., Diri, E., Dikranian, A.H., Cush, J.J., Brodsky, A.L., Bathon, J.M., Baraf, H.S.B., Birbara, C.A., Thorne, J., Khraishi, M., Keystone, E.C., Niall Jones, H., Haraoui, B., Cividino, A.A., Rischmueller, M., Bessette, L., Baker, M.F., Nicholls, D., Hall, S., Fleischmann, R., Connell, C.A., Wallenstein, G., Gruben, D., Tegzová, D., Song, Y.-W., Nash, P., Cohen, S., Cardiel, M.H., Zerbini, C.A.F., Kremer, J., Keystone, E., Tanaka, Y., Strand, V., van der Heijde, D., Arthritis and Rheumatology, 2019, 10.1002/art.40803
  • Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry, Nantel, F., Lehman, A.J., Rampakakis, E., Teo, M., Bessette, L., Haaland, D., Starr, M., Rahman, P., BMC Rheumatology, 2020, 10.1186/s41927-020-00158-z
  • Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks, Deodhar, A., Bessette, L., Li, X., Zhu, B., Sandoval, D., Hunter, T., Baraliakos, X., Wei, J.C.-C., Combe, B., Dougados, M., Strand, V., Navarro-Compán, V., Rahman, P., Mease, P.J., Marzo-Ortega, H., Rheumatology and Therapy, 2020, 10.1007/s40744-020-00225-4
  • Experience with tofacitinib in Canada: Patient characteristics and treatment patterns in rheumatoid arthritis over 3 years, Haraoui, B., Gold, D., Crooks, M., Gruben, D., Woolcott, J., Fallon, L., Jones, N., Bessette, L., Pope, J., Rheumatology (United Kingdom), 2020, 10.1093/rheumatology/kez324
  • Sustainability of Response Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: Results Through 3 Years from the SELECT-COMPARE Trial, Fleischmann, Roy, Suboticki, Jessica, Song, Yanna, Shaw, Tim, Song, In-Ho, Bessette, Louis, Combe, Bernard, Buch, Maya, Kavanaugh, Arthur, Nash, Peter, Arthritis & Rheumatology, 2021
  • Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort, Pope, J.E., Bykerk, V.P., Thorne, C., Tin, D., Keystone, E., Hitchon, C.A., Hazlewood, G., Boire, G., Bessette, L., Bartlett, S.J., Schieir, O., Holdren, M., Arthritis and Rheumatology, 2021, 10.1002/art.41499
  • Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid Arthritis, Zummer, M., Villeneuve, E., Thorne, C., Pope, J., Rubin, L., Panopoulos, P., Nair, B., Keystone, E., Joshi, R., Jamal, S., Hitchon, C., Hazlewood, G., Haraoui, P., Haaland, D., Fallavollita, S., Colmegna, I., Bykerk, V., Boire, G., Bessette, L., Baron, M., Pope, J.E., Bykerk, V.P., Thorne, C., Tin, D., Keystone, E.C., Hitchon, C., Hazlewood, G., Boire, G., Bessette, L., Bartlett, S.J., Valois, M.F., Schieir, O., Fatima, S., Arthritis and Rheumatology, 2021, 10.1002/art.41513
  • Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib, Wollenhaupt, J., Fleishaker, D., Szumski, A., Shapiro, A.B., Wang, L., Woolcott, J., Azevedo, V.F., Nash, P., Bessette, L., Gold, D., Dikranian, A., Rheumatology and Therapy, 2021, 10.1007/s40744-021-00405-w
  • Expression of the myeloid inhibitory receptor CLEC12A correlates with disease activity and cytokines in early rheumatoid arthritis, Fernandes, M.J., Fortin, P.R., Michou, L., Bessette, L., Tessier, P.A., Pelletier, M., Amiable, N., Julien, A.-S., Kerever, A., Lachhab, A., Pagé, N., Paré, G., Desaulniers, P., Vaillancourt, M., Scientific Reports, 2021, 10.1038/s41598-021-90631-7
  • Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis Cohort, Bartlett, Susan J., Bykerk, Vivian P., Keystone, Edward C., Tin, Diane, Boire, Gilles, Pope, Janet, Thorne, Carter, Hazlewood, Glen, Bessette, Louis, Hitchon, Carol, Colmegna, Ines, Valois, Marie-France, Schieir, Orit, Ta, Viviane, ACR Open Rheumatology, 2022, 10.1002/ACR2.11427
  • Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept., Pope J, Trépanier MO, Dembowy J, Rampakakis E, Haraoui B, Bessette L, Arthritis research & therapy, 2023, 10.1186/s13075-023-03151-2
  • Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice, Axel J. Hueber, Louis Bessette, Björn Fritz, Nikola Baschuk, Katharina Jeromin, Tanya Girard, Marie-Claude Laliberté, Martin Bohl-Bühler, Sabine Reckert, Xenofon Baraliakos, Stephanie G. Werner, Rheumatology and Therapy, 2023, 10.1007/s40744-023-00589-3

Contribution à l'enseignement aux cycles supérieurs